Assessment of Neointimal Stent Strut Coverage and Endothelial Function After Second Generation Drug-Eluting Stent Systems.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Biomarker; Pharmacodynamics
- Acronyms ASSESS
- 06 Sep 2013 New source identified and integrated (University Hospital Medical Information Network - Japan; UMIN000003222).
- 06 Apr 2010 Trial acronym (ASSESS), long name and actual initiation date (Apr 2010) added as reported by ClinicalTrials.gov.
- 06 Apr 2010 Planned end date changed from 1 Feb 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.